Mediso and RS2D concluded in 2014 a cooperation agreement on joint the development of 4 new systems to be integrated within the range of preclinical imaging NanoScan, which are:EVOL

To develop these innovative devices the two companies have signed a license agreement allowing Mediso to integrate MRI technology  bringing by RS2D in NanoScan’s system.

Apart from jointly develop part of the range, RS2D has exclusive rights concerning the distribution and sale of all preclinical Mediso products in French speaking territories.